ID

39687

Descripción

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009); ODM derived from: https://clinicaltrials.gov/show/NCT00704405

Link

https://clinicaltrials.gov/show/NCT00704405

Palabras clave

Versiones (1)
  1. 10/2/20 10/2/20 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

10 de febrero de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatitis C, Chronic NCT00704405

Inglés

Eligibility Hepatitis C, Chronic NCT00704405

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
has chronic hcv genotype 1 infection
Descripción

Chronic Hepatitis C Genotype

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C1533728
is treatment-experienced
Descripción

Therapy Experience

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0596545
for the non-cirrhotic population, has had a liver biopsy without evidence of cirrhosis and hepatocellular carcinoma; for the cirrhotic population, has had a liver biopsy with evidence of cirrhosis and without evidence of hepatocellular carcinoma.
Descripción

Liver Cirrhosis Absent Biopsy of liver | Liver carcinoma Absent Biopsy of liver | Liver Cirrhosis Biopsy of liver

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0193388
UMLS CUI [2,1]
C2239176
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0193388
UMLS CUI [3,1]
C0023890
UMLS CUI [3,2]
C0193388
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
has not tolerated previous course peg-ifn and rbv
Descripción

Intolerance to PEGINTERFERON/RIBAVIRIN Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1875630
UMLS CUI [1,3]
C0205156
is unlikely to tolerate at least 24 weeks of continuous therapy with peg-ifn and rbv
Descripción

Intolerance to PEGINTERFERON/RIBAVIRIN Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1875630
UMLS CUI [1,3]
C0449238
is co-infected with human immunodeficiency virus (hiv) and/or hepatitis b
Descripción

Human immunodeficiency virus (HIV) coinfection | HBV coinfection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2]
C2242656
consumes excessive amounts of alcohol
Descripción

Alcohol intake above recommended sensible limits

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0560219
has a history of drug or alcohol abuse
Descripción

Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
if female, participant is pregnant or breastfeeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
has been in a clinical trail with an investigational drug in the last 30 days
Descripción

Study Subject Participation Status | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
has used ifn/peg-ifn and rbv in the last 3 months
Descripción

Use of Interferon Recent | Use of PEGINTERFERON Recent | Use of Ribavirin Recent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1524063
UMLS CUI [1,2]
C3652465
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C1524063
UMLS CUI [2,2]
C0982327
UMLS CUI [2,3]
C0332185
UMLS CUI [3,1]
C1524063
UMLS CUI [3,2]
C0035525
UMLS CUI [3,3]
C0332185
Volver a la parte superior de la página

Similar models

Eligibility Hepatitis C, Chronic NCT00704405

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Hepatitis C Genotype
Item
has chronic hcv genotype 1 infection
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Therapy Experience
Item
is treatment-experienced
boolean
C0087111 (UMLS CUI [1,1])
C0596545 (UMLS CUI [1,2])
Liver Cirrhosis Absent Biopsy of liver | Liver carcinoma Absent Biopsy of liver | Liver Cirrhosis Biopsy of liver
Item
for the non-cirrhotic population, has had a liver biopsy without evidence of cirrhosis and hepatocellular carcinoma; for the cirrhotic population, has had a liver biopsy with evidence of cirrhosis and without evidence of hepatocellular carcinoma.
boolean
C0023890 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0193388 (UMLS CUI [1,3])
C2239176 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0193388 (UMLS CUI [2,3])
C0023890 (UMLS CUI [3,1])
C0193388 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Intolerance to PEGINTERFERON/RIBAVIRIN Previous
Item
has not tolerated previous course peg-ifn and rbv
boolean
C1744706 (UMLS CUI [1,1])
C1875630 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
Intolerance to PEGINTERFERON/RIBAVIRIN Duration
Item
is unlikely to tolerate at least 24 weeks of continuous therapy with peg-ifn and rbv
boolean
C1744706 (UMLS CUI [1,1])
C1875630 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Human immunodeficiency virus (HIV) coinfection | HBV coinfection
Item
is co-infected with human immunodeficiency virus (hiv) and/or hepatitis b
boolean
C4062778 (UMLS CUI [1])
C2242656 (UMLS CUI [2])
Alcohol intake above recommended sensible limits
Item
consumes excessive amounts of alcohol
boolean
C0560219 (UMLS CUI [1])
Substance Use Disorders
Item
has a history of drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
if female, participant is pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status | Investigational New Drugs
Item
has been in a clinical trail with an investigational drug in the last 30 days
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Use of Interferon Recent | Use of PEGINTERFERON Recent | Use of Ribavirin Recent
Item
has used ifn/peg-ifn and rbv in the last 3 months
boolean
C1524063 (UMLS CUI [1,1])
C3652465 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C1524063 (UMLS CUI [2,1])
C0982327 (UMLS CUI [2,2])
C0332185 (UMLS CUI [2,3])
C1524063 (UMLS CUI [3,1])
C0035525 (UMLS CUI [3,2])
C0332185 (UMLS CUI [3,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial